Twelve-month positive outcomes of Zephyr endobronchial valves in severe emphysema patients:  LIBERATE trial

D. Slebos (Groningen, Netherlands), S. Wright (Phoenix, United States of America), R. Sue (Phoenix, United States of America), M. Dransfield (Birmingham, United States of America), H. Rivas-Perez (Louisville, United States of America), T. Wiese (Louisville, United States of America), F. Sciurba (Pittsburgh, United States of America), P. Shah (London, United Kingdom), M. Wahidi (Durham, United States of America), H. De Oliviera (Porto Alegre, Brazil), B. Morrissey (Sacramento, United States of America), P. Cardoso (Sao Paulo, Brazil), S. Hays (San Francisco, United States of America), A. Majid (Boston, United States of America), N. Pastis (Charleston, United States of America), L. Kopas (Houston, United States of America), M. Vollenweider (Orlando, United States of America), P. Mcfadden (Los Angeles, United States of America), M. Machuzak (Cleveland, United States of America), D. Hsia (Torrance, United States of America), A. Sung (Palo Alto, United States of America), N. Jarad (Bristol, United Kingdom), M. Kornaszewska (Cardiff, United Kingdom), S. Hazelrigg (Springfield, United States of America), G. Krishna (Mountain View, United States of America), N. Ten Hacken (Groningen, Netherlands), N. Shargill (Redwood City, United States of America), G. Criner (Philadelphia, United States of America)

Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Session: Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Session type: Oral Presentation
Number: 4932
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Slebos (Groningen, Netherlands), S. Wright (Phoenix, United States of America), R. Sue (Phoenix, United States of America), M. Dransfield (Birmingham, United States of America), H. Rivas-Perez (Louisville, United States of America), T. Wiese (Louisville, United States of America), F. Sciurba (Pittsburgh, United States of America), P. Shah (London, United Kingdom), M. Wahidi (Durham, United States of America), H. De Oliviera (Porto Alegre, Brazil), B. Morrissey (Sacramento, United States of America), P. Cardoso (Sao Paulo, Brazil), S. Hays (San Francisco, United States of America), A. Majid (Boston, United States of America), N. Pastis (Charleston, United States of America), L. Kopas (Houston, United States of America), M. Vollenweider (Orlando, United States of America), P. Mcfadden (Los Angeles, United States of America), M. Machuzak (Cleveland, United States of America), D. Hsia (Torrance, United States of America), A. Sung (Palo Alto, United States of America), N. Jarad (Bristol, United Kingdom), M. Kornaszewska (Cardiff, United Kingdom), S. Hazelrigg (Springfield, United States of America), G. Krishna (Mountain View, United States of America), N. Ten Hacken (Groningen, Netherlands), N. Shargill (Redwood City, United States of America), G. Criner (Philadelphia, United States of America). Twelve-month positive outcomes of Zephyr endobronchial valves in severe emphysema patients:  LIBERATE trial. 4932

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of endobronchial valves on patient reported outcomes in severe emphysema
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Mid-term follow-up data after endoscopic lung volume reduction with nitinol coils in patients with very severe emphysema
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Update on the European multicenter, blinded and randomized study of bronchoscopic placement of valves for the treatment of severe emphysema
Source: Annual Congress 2008 - New trends in interventional pulmonology
Year: 2008


Quality of forced spirometry in a worldwide multicenter clinical trial with moderate to severe COPD patients with emphysema
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results.
Source: International Congress 2017 – Interventional pulmonology highlights 2017
Year: 2017




STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

International multicenter trial of bronchial valve treatment for severe emphysema
Source: Eur Respir J 2007; 30: Suppl. 51, 711s
Year: 2007

Quality of diffusion measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


LATE-BREAKING ABSTRACT: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the spiration valve system intra-bronchial therapy for severe emphysema
Source: International Congress 2016 – Advancements in bronchoscopy
Year: 2016


Does physiotherapy reduce the incidence of postoperative pulmonary complications in patients following pulmonary resection via thoracotomy? A single blind randomised controlled trial
Source: Annual Congress 2009 - Chest physiotherapy in critically ill patients
Year: 2009


Chartis evaluation of collateral ventilation versus HRCT assessment, in predicting clinical outcomes following endobronchial valve therapy (EBV) in COPD patients
Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence
Year: 2012


Home-based pulmonary rehabilitation in patients with bronchiectasis: a randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



LATE-BREAKING ABSTRACT: A multicenter, prospective, randomized, controlled trial of endobronchial valve therapy vs standard of care in homogeneous emphysema (IMPACT)
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support
Year: 2021



The effects of T-PEP on ventilation lung scan in patients with bronchiectasis: Protocol for a randomized controlled trial
Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease
Year: 2010


Factors associated with good response in a cohort of patients with severe emphysema and complete inter-lobar fissures undergoing endo-bronchial valve insertion
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Quality of Helium dilution lung volume measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


One year follow-up after endobronchial valve treatment in patients with emphysema without interlobar collateral ventilation
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016


Lung volume reduction coil treatment for patients with severe heterogeneous emphysema, a multicenter feasibility trial
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Year: 2011